[go: up one dir, main page]

ZA201408055B - Compositions and methods for the treatment of local pain - Google Patents

Compositions and methods for the treatment of local pain

Info

Publication number
ZA201408055B
ZA201408055B ZA2014/08055A ZA201408055A ZA201408055B ZA 201408055 B ZA201408055 B ZA 201408055B ZA 2014/08055 A ZA2014/08055 A ZA 2014/08055A ZA 201408055 A ZA201408055 A ZA 201408055A ZA 201408055 B ZA201408055 B ZA 201408055B
Authority
ZA
South Africa
Prior art keywords
compositions
treatment
methods
local pain
pain
Prior art date
Application number
ZA2014/08055A
Inventor
Mahesh Kandula
Original Assignee
Cellix Bio Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Private Ltd filed Critical Cellix Bio Private Ltd
Publication of ZA201408055B publication Critical patent/ZA201408055B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
ZA2014/08055A 2012-05-10 2014-11-04 Compositions and methods for the treatment of local pain ZA201408055B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1843CH2012 2012-05-10
PCT/IB2013/051268 WO2013168006A2 (en) 2012-05-10 2013-02-16 Compositions and methods for the treatment of local pain

Publications (1)

Publication Number Publication Date
ZA201408055B true ZA201408055B (en) 2016-03-30

Family

ID=54193695

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/08055A ZA201408055B (en) 2012-05-10 2014-11-04 Compositions and methods for the treatment of local pain

Country Status (8)

Country Link
EP (1) EP2882745A2 (en)
JP (1) JP2016508956A (en)
CN (1) CN105612155A (en)
AU (1) AU2013257727B2 (en)
CA (1) CA2873138A1 (en)
SG (1) SG11201407323WA (en)
WO (1) WO2013168006A2 (en)
ZA (1) ZA201408055B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8361067B2 (en) 2002-09-30 2013-01-29 Relievant Medsystems, Inc. Methods of therapeutically heating a vertebral body to treat back pain
JP5688022B2 (en) 2008-09-26 2015-03-25 リリーバント メドシステムズ、インコーポレイテッド System and method for guiding an instrument through the interior of a bone
US10028753B2 (en) 2008-09-26 2018-07-24 Relievant Medsystems, Inc. Spine treatment kits
WO2013101772A1 (en) 2011-12-30 2013-07-04 Relievant Medsystems, Inc. Systems and methods for treating back pain
US10588691B2 (en) 2012-09-12 2020-03-17 Relievant Medsystems, Inc. Radiofrequency ablation of tissue within a vertebral body
JP6195625B2 (en) 2012-11-05 2017-09-13 リリーバント メドシステムズ、インコーポレイテッド System and method for creating a curved pathway through bone and regulating nerves within the bone
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
WO2018122626A1 (en) * 2016-12-26 2018-07-05 Cellix Bio Private Limited Compositions and methods for the treatment of chronic pain
EP4501263A3 (en) 2019-09-12 2025-03-19 Relievant Medsystems, Inc. Systems and methods for tissue modulation
WO2022011115A1 (en) 2020-07-10 2022-01-13 Relievant Medsystems, Inc. Vertebral denervation in conjunction with vertebral fusion
US12082876B1 (en) 2020-09-28 2024-09-10 Relievant Medsystems, Inc. Introducer drill
JP2024505335A (en) 2020-12-22 2024-02-06 リリーバント メドシステムズ、インコーポレイテッド Prediction of spinal neuromodulation candidates
US12433668B1 (en) 2021-11-08 2025-10-07 Relievant Medsystems, Inc. Impedance stoppage mitigation during radiofrequency tissue ablation procedures
GB202305212D0 (en) * 2023-04-06 2023-05-24 Elixa Mediscience Ltd Compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302218D0 (en) * 1993-06-28 1993-06-28 Ab Astra NEW USE
CN1187813A (en) * 1995-05-01 1998-07-15 斯科舍集团有限公司 Fatty acid esters as bioactive compounds
GB9704349D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use
AU740914B2 (en) * 1997-11-19 2001-11-15 Darwin Discovery Limited Anaesthetic formulation
RS20100077A (en) * 2001-04-30 2010-10-31 Trommsdorff Gmbh. & Co. Kg. Arzneimittel Pharamceutically active uridine esters
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US8846068B2 (en) * 2008-04-18 2014-09-30 Warsaw Orthopedic, Inc. Methods and compositions for treating post-operative pain comprising a local anesthetic
WO2013024320A1 (en) * 2011-08-17 2013-02-21 Mahesh Kandula 2, 6 xylidine derivatives for the treatment of pain

Also Published As

Publication number Publication date
SG11201407323WA (en) 2014-12-30
AU2013257727A1 (en) 2014-11-27
AU2013257727B2 (en) 2016-04-28
EP2882745A2 (en) 2015-06-17
WO2013168006A2 (en) 2013-11-14
JP2016508956A (en) 2016-03-24
CN105612155A (en) 2016-05-25
WO2013168006A3 (en) 2016-09-01
CA2873138A1 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
IL266582A (en) Compositions and methods for the treatment of hemoglobinopathies
IL273090B (en) Methods and compositions for the treatment of cancer
IL261768B (en) Devices and methods for the treatment of tissue
ZA201408055B (en) Compositions and methods for the treatment of local pain
EP2675469A4 (en) Compositions, devices and methods of use thereof for the treatment of cancers
HUE041553T2 (en) Methods and compositions for the treatment of monogenic diseases
EP2890440A4 (en) Devices and methods for the treatment of vascular disease
EP2831001A4 (en) Water treatment compositions and methods of use
GB201320723D0 (en) Composition and methods of treatment
IL238177A0 (en) Methods and compositions for the treatment of cancer
EP2958936A4 (en) Methods and compositions for treatment of forbes-cori disease
ZA201408056B (en) Compositions and methods for the treatment of mucositis
IL239921A0 (en) Compositions and methods for treating severe pain
IL239374A0 (en) Compositions and methods for the treatment of brain cancers
SI2900230T1 (en) Compounds for the treatment of obesity and methods of use thereof
PL2968478T3 (en) Compositions and methods for the treatment of carboxyhemoglobinemia
HRP20181761T1 (en) New alfentanil composition for the treatment of acute pain
ZA201408062B (en) Compositions and methods for the treatment of multiple sclerosis
ZA201408057B (en) Compositions and methods for the treatment of moderate to severe pain
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
ZA201408065B (en) Compositions and methods for the treatment of diabetes
ZA201408053B (en) Compositions and methods for the treatment of metabolic syndrome